Bivalirudin vs Heparin With or Without Tirofiban During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

Han, Yaling; Guo, Jincheng; Zheng, Yang; Zang, Hongyun; Su, Xi; Wang, Yu; Chen, Shao‐Liang; Jiang, Tiemin; Yang, Ping; Chen, Jiyan; Jiang, Dong-ju; Jing, Quanmin; Liang, Zhenyang; Liu, Haiwei; Zhao, Xin; Li, Jing; Li, Yi; Xu, Bo; W. Stone, Gregg

doi:10.1001/jama.2015.2323

Public

Bivalirudin vs Heparin With or Without Tirofiban During Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

Published in JAMA • Mar 16, 2015

Authors:

Yaling Han

Jincheng Guo

Yang Zheng

Abstract

IMPORTANCE: The safety and efficacy of bivalirudin compared with heparin with or without glycoprotein IIb/IIIa inhibitors in patients with acute myocardial infarction (AMI) undergoing primary percutaneous coronary intervention (PCI) are uncertain. OBJECTIVE: To determine if bivalirudin is superior t...

Subject

Medicine

Bivalirudin

Tirofiban

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!